|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Fluoride-selective sensors based on polyurethane membranes doped with Zr( IV)-porpbyrins显示文摘 | Lukasz G'orski El zbieta Malinowska | 2005 | Analytiea Chimica Acta2005，，540： | 1 |
| 2 | Detection and differentiation of virulent and avirulent strains of Newcastle disease virus by real-time PCR显示文摘 | Nidzworski D Lukasz R Beats G | | 0，，： | 1 |
| 3 | Angiopoietin-2in adults with congenital heart disease and heart failure显示文摘 | LUKASZ A BEUTEL G KUMPERS P | 2013 | PLoS One2013，8，66： | 1 |
| 4 | Detection and differentiation of virulent and avirulent strains of Newcastle disease virus by real-time PCR显示文摘 | Dawid N W Lukasz R Beata G | 2011 | J Virol Methods2011，173，1： | 1 |
| 5 | Leaf rust resistance genes of wheat:identification in cultivars and resistance sources 显示文摘 | Lukasz S Lidia G Jerzy C | 2003 | Journal of Applied Genetics2003，44，： | 1 |
| 6 | Sampling the repairs of func- tional dependency violations under hard constraints 显示文摘 | GEORGE B IIYAS I F LUKASZ G | 2010 | Proceedings of the VLDB Endowment2010，3，1： | 1 |
| 7 | Biology and Management of Asian Citrus Psyllid, Vector of the Huanglongbing Pathogens显示文摘 | Elizabeth G C E Lukasz S L Philip S A | 2013 | Annual Review of Entomology2013，，58： | 1 |
| 8 | Recent develop- ments and future trends in solid phase microextraction techniques towards green analytical chemistry显示文摘 | Agata S Lukasz M Miguel D L G | 2013 | Journal of Chromatography A2013，1321，24： | 1 |
| 9 | DNA damage and repair in human peripheral blood lymphocytes following treatment with microcystin-LR显示文摘 | Anna L Lukasz K Joanna G | 2004 | Mutat Res2004，559，12： | 1 |
| 10 | Leaf rust resistance genes of wheat:identification in cultivars and resistance sources显示文摘 | Lukasz S Lidia G Jerzy C | 2003 | J Appl Genet2003，44，： | 1 |
| 11 | Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort显示文摘AIM To examine patient-centered outcomes with vasopressin(AVP) use in patients with cirrhosis with catecholaminerefractory septic shock. METHODS We conducted a single center, retrospective cohort study enrolling adult patients with cirrhosis treated for catecholamine-resistant septic shock in the intensive care unit(ICU) from March 2011 through December 2013. Other etiologies of shock were excluded. Multivariable regression models were constructed for seven and 28-d mortality comparing AVP as a second-line therapy to a group of all other vasoactive agents. RESULTS Forty-five consecutive patients with cirrhosis were treated for catecholamine-resistant septic shock; 21 received AVP while the remaining 24 received another agent [phenylephrine(10), dopamine(6), norepinephrine(4), dobutamine(2), milrinone(2)]. In general,no significant differences in baseline demographics, etiology of cirrhosis, laboratory values, vital signs or ICU mortality/severity of illness scores were observed with the exception of higher MELD scores in the AVP group(32.4, 95%CI: 28.6-36.2 vs 27.1, 95%CI: 23.6-30.6, P = 0.041). No statistically significant difference was observed in unadjusted 7-d(52.4% AVP vs 58.3% and P = 0.408) or 28-d mortality(81.0% AVP vs 87.5% non-AVP, P = 0.371). Corticosteroid administration was associated with lower 28-d mortality(HR = 0.37, 95%CI: 0.16-0.86, P = 0.021) independent of AVP use. CONCLUSION AVP is similar in terms of patient centered outcomes of seven and 28-d mortality, in comparison to all other vasopressors when used as a second line vasoactive agent in catecholamine resistant septic shock. Large-scale prospective study would help to refine current consensus standards and provide further support to our findings. | Lukasz A Myc Jonathan G Stine Rinita Chakrapani Alexandra Kadl Curtis K Argo | 2017 | World Journal of Hepatology2017，9，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员